• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后韩国女性骨质疏松症治疗期间及治疗后骨小梁骨评分的纵向变化

Longitudinal Change in Trabecular Bone Score during and after Treatment of Osteoporosis in Postmenopausal Korean Women.

作者信息

Shin Mi-Seon, Cho Eun-Hee, Kim Ha Young

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Hanil General Hospital, Seoul, Korea.

Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Kangwon National University, Chuncheon, Korea.

出版信息

J Bone Metab. 2017 May;24(2):117-124. doi: 10.11005/jbm.2017.24.2.117. Epub 2017 May 31.

DOI:10.11005/jbm.2017.24.2.117
PMID:28642856
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5472798/
Abstract

BACKGROUND

The aim of this study was to evaluate the longitudinal changes of trabecular bone score (TBS) during and after bisphosphonate (BP) treatment in postmenopausal Korean women with osteoporosis.

METHODS

We analyzed 191 patients who took BP and underwent bone mineral density (BMD) test for the period from January 2010 to December 2015. The mean follow up period during treatment and after treatment was 22.8 months and 18 months, respectively. The TBS and BMD values were evaluated by the percent changes relative to the baseline.

RESULTS

In 191 patients, who treated with BPs, L-spine BMD increased 3.65±0.5% and TBS increased 0.26±0.4% from baseline during first 1 year. At 2 to 4 years, the changes of BMD and TBS from baseline gradually increased up to 9.3±3.25% and 2.69±0.98% and both results showed statistically significant correlation. In 86 patients who stopped BPs, L-spine BMD decreased -0.54±1.07% and TBS increased 0.33±1.96% from baseline during 3 years follow up period.

CONCLUSIONS

Lumbar spine TBS increase over time with BPs treatment although the changes were less than that of BMD. Also, it preserve for years after stopping treatment, as the changes of lumbar spine BMD. The results of BMD and TBS showed significant correlation during treatment but not during drug withdrawal.

摘要

背景

本研究旨在评估双膦酸盐(BP)治疗期间及治疗后绝经后韩国骨质疏松症女性的小梁骨评分(TBS)的纵向变化。

方法

我们分析了191例在2010年1月至2015年12月期间服用BP并接受骨密度(BMD)检测的患者。治疗期间和治疗后的平均随访期分别为22.8个月和18个月。TBS和BMD值通过相对于基线的百分比变化进行评估。

结果

在191例接受BP治疗的患者中,第1年腰椎BMD较基线增加3.65±0.5%,TBS增加0.26±0.4%。在2至4年时,BMD和TBS相对于基线的变化逐渐增加至9.3±3.25%和2.69±0.98%,两者结果均显示出统计学上的显著相关性。在86例停止服用BP的患者中,在3年随访期内,腰椎BMD较基线下降-0.54±1.07%,TBS增加0.33±1.96%。

结论

尽管变化小于BMD,但腰椎TBS随BP治疗时间的推移而增加。而且,与腰椎BMD的变化一样,停药后其仍能保持数年。BMD和TBS的结果在治疗期间显示出显著相关性,但在停药期间则不然。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3677/5472798/28a166a61ada/jbm-24-117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3677/5472798/dcef11330168/jbm-24-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3677/5472798/28a166a61ada/jbm-24-117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3677/5472798/dcef11330168/jbm-24-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3677/5472798/28a166a61ada/jbm-24-117-g002.jpg

相似文献

1
Longitudinal Change in Trabecular Bone Score during and after Treatment of Osteoporosis in Postmenopausal Korean Women.绝经后韩国女性骨质疏松症治疗期间及治疗后骨小梁骨评分的纵向变化
J Bone Metab. 2017 May;24(2):117-124. doi: 10.11005/jbm.2017.24.2.117. Epub 2017 May 31.
2
Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.特立帕肽与伊班膦酸钠对绝经后骨质疏松症女性脊柱骨密度(BMD)和微结构(TBS)的比较影响:一项为期2年的开放标签研究。
Osteoporos Int. 2014 Jul;25(7):1945-51. doi: 10.1007/s00198-014-2703-8. Epub 2014 Apr 24.
3
Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.地舒单抗对绝经后骨质疏松症女性的小梁骨评分的影响。
Osteoporos Int. 2017 Oct;28(10):2967-2973. doi: 10.1007/s00198-017-4140-y. Epub 2017 Jul 26.
4
Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.抗吸收药物对老年女性的骨小梁评分(TBS)的影响。
Osteoporos Int. 2013 Mar;24(3):1073-8. doi: 10.1007/s00198-012-2155-y. Epub 2012 Oct 3.
5
Longitudinal changes in bone mineral density and trabecular bone score in Korean adults: a community-based prospective study.韩国成年人骨密度和小梁骨评分的纵向变化:一项基于社区的前瞻性研究。
Arch Osteoporos. 2020 Jul 3;15(1):100. doi: 10.1007/s11657-020-00731-6.
6
Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.印度南部一项回顾性前瞻性研究:绝经后骨质疏松症患者每年唑来膦酸输注后骨密度和小梁骨评分的纵向变化。
Arch Osteoporos. 2019 Jul 18;14(1):79. doi: 10.1007/s11657-019-0630-1.
7
Spine trabecular bone scores and bone mineral density of postmenopausal Taiwanese women.绝经后台湾女性的脊柱小梁骨评分和骨密度。
Menopause. 2022 Nov 1;29(11):1308-1314. doi: 10.1097/GME.0000000000002058. Epub 2022 Sep 20.
8
Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study.唑来膦酸对比安慰剂对骨质疏松绝经后妇女脊柱骨密度和骨小梁骨评分评估的微结构的影响:一项为期三年的研究。
J Bone Miner Res. 2013 Mar;28(3):449-54. doi: 10.1002/jbmr.1775.
9
Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort.抗吸收治疗后小梁骨评分(TBS)的变化不能预测女性骨折:曼尼托巴骨密度队列研究
J Bone Miner Res. 2017 Mar;32(3):618-623. doi: 10.1002/jbmr.3054. Epub 2016 Dec 29.
10
Contributions of Clinical and Technical Factors to Longitudinal Change in Trabecular Bone Score and Bone Density: A Registry-Based Individual-Level Analysis.临床和技术因素对小梁骨评分及骨密度纵向变化的贡献:基于登记处的个体水平分析
J Bone Miner Res. 2023 Apr;38(4):512-521. doi: 10.1002/jbmr.4774. Epub 2023 Jan 30.

引用本文的文献

1
Bone Mineral Density and Trabecular Bone Score Changes throughout Menopause in Women with HIV.绝经后 HIV 感染女性的骨密度和小梁骨评分变化。
Viruses. 2023 Dec 1;15(12):2375. doi: 10.3390/v15122375.
2
Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Foundation (IOF) under the auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging.有关在骨质疏松症管理中使用小梁骨评分 (TBS) 的临床应用的最新情况:欧洲临床和经济骨质疏松症、骨关节炎和肌肉骨骼疾病学会 (ESCEO) 与国际骨质疏松基金会 (IOF) 在世界卫生组织协作中心的主持下举办的专家组会议的结果,该中心负责骨骼肌肉健康和老龄化的流行病学。
Osteoporos Int. 2023 Sep;34(9):1501-1529. doi: 10.1007/s00198-023-06817-4. Epub 2023 Jul 1.
3

本文引用的文献

1
Comparison between different bone treatments on areal bone mineral density (aBMD) and bone microarchitectural texture as assessed by the trabecular bone score (TBS).通过小梁骨评分(TBS)评估不同骨治疗对骨面积骨密度(aBMD)和骨微结构纹理的比较。
Bone. 2015 Jun;75:138-43. doi: 10.1016/j.bone.2014.12.062. Epub 2015 Jan 6.
2
The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT).唑来膦酸治疗骨质疏松症6年与9年的效果:HORIZON关键骨折试验(PFT)的随机二次延长期研究
J Bone Miner Res. 2015 May;30(5):934-44. doi: 10.1002/jbmr.2442.
3
Trabecular Bone Score and Central Quantitative Computed Tomography for the Prediction of Vertebral Fragility Fractures in Postmenopausal Women.小梁骨评分和中心定量计算机断层扫描用于预测绝经后女性椎体脆性骨折
J Bone Metab. 2023 Feb;30(1):77-86. doi: 10.11005/jbm.2023.30.1.77. Epub 2023 Feb 28.
4
Application of the Trabecular Bone Score in Clinical Practice.小梁骨评分在临床实践中的应用。
J Bone Metab. 2021 May;28(2):101-113. doi: 10.11005/jbm.2021.28.2.101. Epub 2021 May 31.
5
Effect of tamoxifen with or without gonadotropin-releasing hormone analog on DXA values in women with breast cancer.乳腺癌妇女应用他莫昔芬联合或不联合促性腺激素释放激素类似物对 DXA 值的影响。
Sci Rep. 2021 Feb 9;11(1):3407. doi: 10.1038/s41598-021-82824-x.
6
A High-Intensity Exercise Intervention Improves Older Women Lumbar Spine and Distal Tibia Bone Microstructure and Function: A 20-Week Randomized Controlled Trial.高强度运动干预改善老年女性腰椎和胫骨远端骨微结构及功能:一项为期20周的随机对照试验。
IEEE J Transl Eng Health Med. 2020 Jan 3;8:2100108. doi: 10.1109/JTEHM.2019.2963189. eCollection 2020.
7
The Relationship between Risk Factors for Metabolic Syndrome and Bone Mineral Density in Menopausal Korean Women.韩国绝经后女性代谢综合征危险因素与骨密度的关系
Iran J Public Health. 2019 Jun;48(6):1025-1032.
Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
特立帕肽与伊班膦酸钠对绝经后骨质疏松症女性脊柱骨密度(BMD)和微结构(TBS)的比较影响:一项为期2年的开放标签研究。
Osteoporos Int. 2014 Jul;25(7):1945-51. doi: 10.1007/s00198-014-2703-8. Epub 2014 Apr 24.
4
Trabecular bone score: a noninvasive analytical method based upon the DXA image.小梁骨评分:一种基于双能X线吸收测定(DXA)图像的非侵入性分析方法。
J Bone Miner Res. 2014 Mar;29(3):518-30. doi: 10.1002/jbmr.2176.
5
Added value of trabecular bone score to bone mineral density for prediction of osteoporotic fractures in postmenopausal women: the OPUS study.基于骨小梁骨评分对绝经后妇女骨质疏松性骨折预测的附加价值:OPUS 研究。
Bone. 2013 Nov;57(1):232-6. doi: 10.1016/j.bone.2013.07.040. Epub 2013 Aug 12.
6
Spine trabecular bone score subsequent to bone mineral density improves fracture discrimination in women.骨密度后脊柱小梁骨评分可提高女性骨折鉴别能力。
J Clin Densitom. 2014 Jan-Mar;17(1):60-5. doi: 10.1016/j.jocd.2013.05.001. Epub 2013 Jun 13.
7
Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer.依西美坦和他莫昔芬治疗对乳腺癌患者 TBS 评估的骨纹理分析与 DXA 评估的骨密度的影响。
J Clin Densitom. 2014 Jan-Mar;17(1):66-71. doi: 10.1016/j.jocd.2013.03.003. Epub 2013 Apr 3.
8
Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis.双膦酸盐类药物与转子下、股骨干和非典型股骨骨折风险:系统评价和荟萃分析。
J Bone Miner Res. 2013 Aug;28(8):1729-37. doi: 10.1002/jbmr.1893.
9
Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.抗吸收药物对老年女性的骨小梁评分(TBS)的影响。
Osteoporos Int. 2013 Mar;24(3):1073-8. doi: 10.1007/s00198-012-2155-y. Epub 2012 Oct 3.
10
Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: a three-year study.唑来膦酸对比安慰剂对骨质疏松绝经后妇女脊柱骨密度和骨小梁骨评分评估的微结构的影响:一项为期三年的研究。
J Bone Miner Res. 2013 Mar;28(3):449-54. doi: 10.1002/jbmr.1775.